A shadow market for unapproved slimming medications is being driven by TikTok fitness influencers and vendors on messaging platforms, based on new investigations.
Experimental Treatment Acquiring Traction Via Social Media
Retatrutide, which remains in research studies, is being promoted by social media influencers for its supposed weight-reducing effects. Viewers are urged to message these accounts privately for source information, while also receiving promotional offers.
Thriving Commerce on Social Networks
Additionally, a robust market exists on Telegram, where groups with thousands of participants share “before and after” images, administration instructions and claims of next-day UK delivery. Vendors promote the substance there before redirecting buyers to WhatsApp for purchases.
Understanding The Experimental Drug
This medication is an experimental injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help patients lose up to a quarter of their total weight. Nicknamed the “triple G”, the drug is being promoted digitally as the successor to Ozempic.
Medical Professionals Express Worries
However, doctors and pharmacists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is worrisome and could lead to individuals administering substances of uncertain source.
Some professionals said the popularity for retatrutide could be connected to the increasing price of licensed weight loss products such as Mounjaro.
Regulatory Status and Enforcement
Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be marketed or distributed for human use under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still violate pharmaceutical, advertising, and customer laws, potentially leading to penalties, prosecution or imprisonment.
Service Reaction and Material Removal
According to TikTok, the service has removed problematic content and prohibited related keywords and search suggestions. The organization stated it was dedicated to maintaining the platform safe and allocating resources in strengthening enforcement strategies.
Digital Marketplace Operations
Investigations also found groups with up to 9,000 members selling retatrutide using the platform's integrated search feature, which functions like a public directory. Entering “retatrutide” immediately displays groups with numerous of users, filled with photos of weight loss, positive testimonials and step-by-step instructions for preparing or administering at residence.
Within minutes of entering one community, a vendor shared contact information, where most purchases take place. The vendor sent an guidebook and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about body mass, medical conditions or previous experience.
Product Details and Pricing
Inside these communities, posts show black plastic parcels with Royal Mail labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at home with sterile water, or pre-filled injectors usually priced at £160 for 20 milligrams. When asked how long a injector should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for Telegram said it regularly moderated dangerous material on its service including material that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“People are administering substances they cannot confirm. Even if the science behind retatrutide is sound, these online products may not contain what they claim,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.
A medical professional of Asda Online Doctor connected the surge in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With prices rising, individuals are turning to social media. But counterfeit injections are extremely risky. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she explained.
Her staff has previously seen individuals injured by personal administration from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your well-being,” said the doctor. “These materials could be impure or improperly measured.”
Manufacturer Position
A representative from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can market [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company investigational product not yet authorized … may expose patients to potentially serious medical dangers”.
